BriaCell Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
BriaCell Therapeutics Total Assets Growth & History (BCTX)
BriaCell Therapeutics's total assets was $21.6M for fiscal 2025.
View full BriaCell Therapeutics company overviewBriaCell Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-07-31 | $21.6M | $15.8M | +268.68% |
| 2024 | 2024-07-31 | $5.9M | −$21.3M | −78.38% |
| 2023 | 2023-07-31 | $27.2M | −$15.4M | −36.20% |
| 2022 | 2022-07-31 | $42.6M | −$15.5M | −26.65% |
| 2021 | 2021-07-31 | $58.0M | $57.5M | +11012.45% |
| 2020 | 2020-07-31 | $522,331 | — | — |
BriaCell Therapeutics quarterly total assets
Q4.20
Q4.21
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-04-30 | $27.1M | $10.1M | +59.23% |
| Q2 2026 | 2026-01-31 | $33.6M | $24.2M | +258.78% |
| Q1 2026 | 2025-10-31 | $13.1M | $2.7M | +25.55% |
| Q4 2025 | 2025-07-31 | $21.6M | $15.8M | +268.68% |
| Q3 2025 | 2025-04-30 | $17.0M | $10.8M | +174.08% |
| Q2 2025 · Jan 31 | 2025-01-31 | $9.4M | −$2.9M | −23.44% |
| Q1 2025 | 2024-10-31 | $10.4M | −$8.2M | −44.07% |
| Q4 2024 | 2024-07-31 | $5.9M | −$21.3M | −78.38% |
| Q3 2024 | 2024-04-30 | $6.2M | −$23.5M | −79.13% |
| Q2 2024 | 2024-01-31 | $12.2M | −$21.9M | −64.20% |
| Q1 2024 | 2023-10-31 | $18.6M | −$19.8M | −51.58% |
| Q4 2023 | 2023-07-31 | $27.2M | −$15.4M | −36.20% |
| Q3 2023 | 2023-04-30 | $29.7M | −$16.7M | −36.03% |
| Q2 2023 | 2023-01-31 | $34.2M | −$14.4M | −29.64% |
| Q1 2023 | 2022-10-31 | $38.5M | — | — |
| Q4 2022 | 2022-07-31 | $42.6M | −$15.5M | −26.65% |
| Q3 2022 | 2022-04-30 | $46.5M | — | — |
| Q2 2022 | 2022-01-31 | $48.6M | — | — |
| Q4 2021 | 2021-07-31 | $58.0M | $57.5M | +11012.45% |
| Q4 2020 | 2020-07-31 | $522,331 | — | — |
BriaCell Therapeutics total assets trends
Over the last five fiscal years, BriaCell Therapeutics's total assets increased from $522,331 to $21.6M, a change of $21.1M. The latest reported quarter, Q3 2026, shows $27.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BriaCell Therapeutics source filings ↗